Globeflex Capital’s NeoGenomics NEO Stock Holding History

Globeflex Capital’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-65,923	Closed	-$1.45M	–	532
2019 Q2	$1.45M	Hold	65,923	–	–	0.3%	90
2019 Q1	$1.35M	Buy	+65,923	New	+$1.15M	0.29%	106
2016 Q1	–	Sell	-23,200	Closed	-$183K	–	475
2015 Q4	$183K	Sell	23,200 -146,600	-86%	-$1.07M	0.05%	317
2015 Q3	$973K	Buy	+169,800	New	+$1.05M	0.21%	161
2015 Q2	–	Sell	-94	Closed	–	–	552
2015 Q1	$0	Sell	94 -47	-33%	-$204	﹤0.01%	574
2014 Q4	$1K	Sell	141 -34	-19%	-$156	﹤0.01%	449
2014 Q3	$1K	Sell	175 -163	-48%	-$837	﹤0.01%	467
2014 Q2	$1K	Buy	338 +81	+32%	+$269	﹤0.01%	512
2014 Q1	$0	Hold	257	–	–	﹤0.01%	668
2013 Q4	$0	Buy	+257	New	+$892	﹤0.01%	670

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Globeflex Capital's NEO Position: Q3 2019 in Review

Globeflex Capital sold out of NeoGenomics (NEO) in Q3 2019, closing a stake of 65,923 shares — an estimated $1.45M sold.

Globeflex Capital first reported a position in NEO in Q4 2013 and held it in 10 quarters. The position peaked at $1.45M in Q2 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

Globeflex Capital reported no remaining NeoGenomics position as of Q3 2019 after selling out during the quarter.
Globeflex Capital sold 65,923 NeoGenomics shares in Q3 2019, an estimated $1.45M.
Globeflex Capital first reported a position in NeoGenomics in Q4 2013 and held it in 10 quarters.
Globeflex Capital's NeoGenomics position peaked at $1.45M in Q2 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Globeflex Capital's 13F filing for Q3 2019, filed 13 Nov 2019.